Karna D Shinde invests in Navaux to transform early cancer detection
Navaux’s ACTIVH test predicts cancer onset years in advance and monitors treatment efficacy, providing real-time insights
Navaux’s ACTIVH test predicts cancer onset years in advance and monitors treatment efficacy, providing real-time insights